Affiliates in the News

Featured

Health

FDA Seems Poised to Approve a New Drug for ALS, but Does it Work?

Holly Fernandez Lynch

NPR

September 21, 2022

More In the News

Business

Investors Who Put $2 Billion Into FTX Face Scrutiny, Too

Kevin Werbach

New York Times

November 11, 2022

Health

Preterm Birth Drug Makena Ignites Argument Over Health Equity

Holly Fernandez Lynch

Bloomberg Law

November 10, 2022

Business

Work Requirements and Income Requirements, Explained

Ioana Marinescu

Niskanen Center

November 8, 2022

Process

Supreme Court Aims Anti-Regulatory Campaign at a Pair of Federal Watchdogs

Jill Fisch

Bloomberg

November 7, 2022

Business

What the Blocked Penguin and Simon & Schuster Merger Could Mean for the Kroger-Albertson’s Deal

Herbert Hovenkamp

Quartz

November 7, 2022

Technology

Influencers Debate Leaving TWITTER, but Where Would They Go?

Cary Coglianese

AP News

November 5, 2022

Technology

Here’s why we’re not prepared for the next wave of biotech innovation

Holly Fernandez Lynch

STAT News

November 3, 2022

Technology

Tesla’s Elon Musk faces trial, again—this time over his $56 billion paycheck that’s the ‘largest in human history’

Jill Fisch

Fortune

November 2, 2022

Health

Seeking Psychedelics? Check the Data Privacy Clause

Holly Fernandez Lynch

Wired

November 2, 2022

Business

A Year After Trading Scandal, Fed Is Again Under Ethics Spotlight

Peter Conti-Brown

Reuters

November 1, 2022

(Visited 261 times, 1 visits today)

Last modified: September 25, 2022

Comments are closed.